BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 288 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,520 | -66.0% | 90 | -50.0% | 0.00% | – |
Q2 2023 | $13,291 | +74.8% | 180 | +100.0% | 0.00% | – |
Q1 2023 | $7,603 | +94937.5% | 90 | 0.0% | 0.00% | – |
Q4 2022 | $8 | -99.9% | 90 | -10.0% | 0.00% | – |
Q3 2022 | $9,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q2 2022 | $9,000 | -50.0% | 100 | -49.7% | 0.00% | – |
Q1 2022 | $18,000 | +63.6% | 199 | +101.0% | 0.00% | – |
Q4 2021 | $11,000 | +22.2% | 99 | +10.0% | 0.00% | – |
Q3 2021 | $9,000 | 0.0% | 90 | -10.0% | 0.00% | – |
Q2 2021 | $9,000 | -25.0% | 100 | -20.0% | 0.00% | – |
Q1 2021 | $12,000 | +100.0% | 125 | +145.1% | 0.00% | – |
Q4 2020 | $6,000 | 0.0% | 51 | -17.7% | 0.00% | – |
Q3 2020 | $6,000 | +20.0% | 62 | 0.0% | 0.00% | – |
Q2 2020 | $5,000 | +66.7% | 62 | +72.2% | 0.00% | – |
Q1 2020 | $3,000 | -97.1% | 36 | -97.2% | 0.00% | -100.0% |
Q4 2019 | $103,000 | +9.6% | 1,278 | 0.0% | 0.01% | +33.3% |
Q3 2019 | $94,000 | +9300.0% | 1,278 | +5456.5% | 0.01% | – |
Q4 2018 | $1,000 | -50.0% | 23 | 0.0% | 0.00% | – |
Q3 2018 | $2,000 | – | 23 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |